Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery ; (12): 154-158, 2023.
Article in Chinese | WPRIM | ID: wpr-953773

ABSTRACT

@#Obesity, sleep disorders, psychological stress, sedentary are modifiable cardiovascular risk factors. There is growing evidence that these risk factors may accelerate the chronic inflammatory process of atherosclerosis and lead to myocardial infarction. Studies on the role of immune cells and their related immune mechanisms in atherosclerosis have shown that the above modifiable risk factors can affect the hematopoiesis of the bone marrow system, affect the production of immune cells and phenotypes, and then affect the progress of atherosclerosis. This review will focus on the effects of modifiable cardiovascular risk factors on the progression of atherosclerosis through the role of the innate immune system.

2.
Chinese Pharmacological Bulletin ; (12): 1052-1058, 2022.
Article in Chinese | WPRIM | ID: wpr-1014062

ABSTRACT

Aim To explore the effects of Panax notog- inseng saponins( PNS) on hematopoietic functions anrl regulation on the TLR4/TLR2-NF-kB signaling path¬way in immune-mediated aplastic anemia ( AA ) C57 mice.Methods C57BL/6 mice were randomly divid¬ed into control group, total body irradiation group ( TBI) , model group, cyclosporine treatment group, PNS low-dose group, medium-dose group and high-dose group.The immune-mediated A A mice model was es¬tablished by total body irradiation with 5.0 Gy X-ray and mixed lymphocyte infusion.The body weight was measured, the spleen and thymus index was calculated , bone marrow pathology, the levels of peripheral blood triline cells,bone marrow nucleated cells( BMCs) and the levels of serum TNF-cx , 1L-2 , 1L-10 were detected, and the expression of CD1 lc and proteins related to the TLR4/TLR2-N F- k B pathway were detected 15 days later.Results Compared with control group, body weight, thymus index, the number of peripheral blood triline cells, BMCs and serum 1L-10 levels of the mice in model group significantly decreased ( P < 0.05 ) , while spleen index, the serum TNF-a, IL-2 levels and the protein expression of CD 11 c, TLR4, TLR2 , MvD88 , Akt and NF-kB in hone marrow significantly increased ( P <0.05).Compared with model group, after PNS treatment, hodv weight, thymus index, the number of peripheral blood triline cells, BMCs and serum IL-10 levels increased.Spleen index,serum TNF-cx,lL-2 lev¬els and the expression of CD11 c, TLR4, TLR2, NF-kB and Akt in bone marrow decreased, and the therapeutic effect was not dose-dependent.There was no signifi¬cant change in the expression of MvD88 and MAPK proteins.Conclusions PNS can improve AA bone marrow injury, regulate immune disoders and promote hematopoiesis, which may be related to the regulation of the number of DCs and the TLH4/TLH2 - Akt- NF-kB pathway in bone marrow.

3.
Chinese Journal of Tissue Engineering Research ; (53): 3966-3973, 2020.
Article in Chinese | WPRIM | ID: wpr-847317

ABSTRACT

BACKGROUND: A large number of studies mainly concern the proliferation effect of mesenchymal stem cells on hematopoietic stem cells in vitro and that bone marrow mesenchymal stem cell transplantation can reduce the death of hematopoietic cells caused by irradiation, increase the survival of bone marrow cells and repair hematopoiesis, while few of them investigate the repair of human umbilical cord blood mesenchymal stem cells transplantation on bone marrow hematopoiesis injury. OBJECTIVE: To explore the repair of hematopoietic microenvironment of bone marrow by human umbilical cord blood mesenchymal stem cells. METHODS: Male BALB/c mice were randomly divided into three groups. The mice in experimental group and control group were irradiated with total dose of 6-Gy X-ray to establish a mouse model of bone marrow hematopoietic injury. The normal group contained untreated normal mice. In the experimental group, CM-DiL labeled human umbilical cord blood mesenchymal stem cells were injected into the tail vein of each mouse at 5×106 (0.2 mL). The control group and the normal group received normal saline 0.2 mL through the tail vein. The peripheral blood hematology and bone marrow hematopoietic microenvironment repair were observed at 1, 5, 7, 14 and 21 days after cell transplantation. RESULTS AND CONCLUSION: Peripheral blood condition: At 1, 5 and 7 days after transplantation, the leucocyte, platelet, erythrocyte count and hemoglobin concentration in the experimental group and control group decreased progressively compared with the normal group. The most obvious decrease occurred on day 7. The trilineage recovered on day 14 after transplantation, basically returned to normal on day 21 after transplantation. Compared with the experimental group, the decrease of the trilineage in the control group was more obvious. The recovery was obvious faster in the experimental group than in the control group on day 14 after transplantation. Bone marrow smears: Bone marrow smears showed that the hematopoietic function was inhibited in the experimental group and the control group at 1, 5, 7, and 14 days after transplantation, especially on day 7. Bone marrow proliferation recovered on day 14 after transplantation. It was better in the experimental group than in the control group. On day 21 after transplantation, the hematopoietic function of bone marrow of mice in the experimental group and the control group recovered, and there was no difference between the experimental group and the control group compared with the normal group. Bone marrow pathological section: Bone marrow pathological sections showed that at 1, 5, 7, and 14 days after transplantation, the hematopoietic function of bone marrow in the experimental group and the control group was inhibited. On day 14 after transplantation, the bone marrow hematopoietic function of the experimental group and the control group began to recover, but the bone marrow proliferation of the experimental group was better than that of the control group. On day 21 after transplantation, there was no difference in the bone marrow proliferation between the experimental and the control groups and the normal group. The results suggested that human umbilical cord blood mesenchymal stem cells can promote the recovery of hematopoietic function of bone marrow.

4.
Chinese Journal of Radiological Medicine and Protection ; (12): 570-575, 2017.
Article in Chinese | WPRIM | ID: wpr-615477

ABSTRACT

Objective To observe the effect and the mechanisms of ferulic acid on radiationinduced damage of mice peripheral blood and bone marrow hematopoietic function.Methods Ninety-six mice were randomly divided into sham irradiation group,irradiation group,positive drug group and 10,30,90 mg·kg-1 ·d-1 ferulic acid group,16 mice per group.Mice were exposed to 3.5 Gy γ-rays 24 h after first drug taken.Then,mice were given drugs for 7 d after irradiation.White blood cells in peripheral blood of 10 mice per group were counted 2 d before irradiation and 3,7,10,15 and 22 days after irradiation.The bone narrow of the other six mice was taken to detect the micronuclei frequency of polychromatic erythrocyte,the hematopoietic progenitor cell colony formation capacity,Thbd and HMGB1 protein expressions in mice bone marrow on the seventh day after irradiation.Results Compared with the irradiation alone group,the treatment of mice with ferulic acid 90 mg· kg-1 · d-1 increased the number of white blood cells in peripheral blood at 3,10,15 and 22 d after irradiation (t =2.267,2.399,1.945,2.828,P < 0.05).Treatment with mice with ferulic acid 90 mg· kg-1 · d 1 decreased the micronuclei rate of erythrocytes in irradiated bone marrow (t =4.013,P < 0.05),increased the clone numbers of CFU-E,BFU-E and CFU-GM of hematopoietic progenitor cells (t =2.366,2.953,3.115,P <0.05),improved the relative expression of the Thbd protein in bone marrow and the HMGB1 protein in nuclear (t =17.75,23.39,P < 0.01).Conclusions Ferulilc acid could protect the bone marrow hematopoietic of mice exposed to irradiation by regulating the expressions of Thbd and HMGB1 protein,and then accelerate the peripheral cells recovery.

5.
Chinese Traditional and Herbal Drugs ; (24): 121-128, 2017.
Article in Chinese | WPRIM | ID: wpr-853068

ABSTRACT

Objective: To investigate the effects of different proportion combinations of Astragalus and Angelica on bone marrow hematopoiesis suppression induced by Cyclophosphamide (CTX) in mice, and to analysis their interactions. Methods: The model of bone marrow hematopoietic function suppression in mice was established by ip injection of CTX. Recombinant human granulocyte-macrophage colony-stimulating factor (rhG-CSF) was used as the positive control drug, ICR mice in the drug groups were administered with the extracts of Astragalus, Angelica, and combinations of Astragalus and Angelica with different ratios (10:1, 5:1, 2.5:1, 1:1, 1:2.5, 1:5, and 1:10). To detect peripheral hemogram, the nucleated cell count in bone marrow (BMNC), the area of bone marrow hematopoietic tissue, spleen index (SI), as well as the contents of hematopoietic growth factor (HGF) in serum such as Erythropoietin (EPO), thrombopoietin (TPO), and Granulocyte-macrophage colony-stimulating factor (GM-CSF). To integrate all the test parameters using comprehensive index method, then to analyze the interaction between Astragalus and Angelica through multiple linear regression analysis. Results: Following continuous CTX injection for 3 d, peripheral hemogram significantly decreased, accompanied by GM-CSF and TPO contents declined, BMNC reduced, SI elevated, and bone marrow hematopoietic tissue area lessened from day 5 to day 7 after injection. Single Astragalus had no remarkable effects on peripheral hemogram, HGF contents, bone marrow hematopoietic tissue area and BMNC. Except for HGF and BMNC, Angelica alone could increase the numbers of WBC, RBC, and PLT in the peripheral blood, raise the area of bone marrow hematopoietic tissue. Astragalus mixed Angelica with the ratios of 5:1, 2.5:1, 1:1, 1:2.5, 1:5, and 1:10 could increase the numbers of WBC, RBC, and PLT along with HGF content, BMNC and bone marrow hematopoietic tissue area, while decreased SI. The comprehensive effect analysis displayed that the effects of Astragalus-Angelica with 1:1, 1:2.5, and 1:5 ratios on promoting hematopoiesis were strongest. The interaction analysis revealed Angelica played a greater role in advancing hematopoiesis than Astragalus did after being combined, meanwhile, the interaction of Astragalus combined with Angelica produced a nonnegligible positive effect on promoting hematopoiesis, namely synergism. Conclusion: Astragalus-Angelica compatilibity has the synergism on promoting hematopoiesis, which is better when the combination ratio of Astragalus and Angelica is 1:1, 1:2.5, or 1:5, furthermore, the effect of Angelica is greater than that of Astragalus.

SELECTION OF CITATIONS
SEARCH DETAIL